Table 3 Changes in plasma B-type natriuretic peptide concentrations and left ventricular function in the control and carnitine group
Before | 6 months | 12 months | |
|---|---|---|---|
Control group (n = 26) | |||
Plasma B-type natriuretic peptide, ng/L | 291.2 ± 174.6 | 285.6 ± 165.9 | 310.1 ± 168.8 |
Left ventricular ejection fraction, % | 52.2 ± 4.8 | 52.0 ± 5.7 | 51.9 ± 6.0 |
Left ventricular mass index, g/m2 | 126.4 ± 24.1 | 126.3 ± 25.1 | 126.5± 23.8 |
Mitral early to atrial (E/A) wave velocity ratio | 1.1 ± 0.6 | 1.1 ± 0.7 | 1.1 ± 0.6 |
Carnitine group (n = 27) | |||
Plasma B-type natriuretic peptide, ng/L | 249.2 ± 229.1 | 274.2 ± 213.2 | 360.2 ± 440.3 |
Left ventricular ejection fraction, % | 53.2 ± 11.9 | 54.0 ± 11.7 | 53.7 ± 9.5 |
Left ventricular mass index, g/m2 | 126.6 ± 24.8 | 138.0 ± 39.3 | 140.9 ± 34.8* |
Mitral early to atrial (E/A) wave velocity ratio | 1.2 ± 0.5 | 1.1 ± 0.6 | 1.1 ± 0.6 |